On July 28, Hca Healthcare Inc rose 3.53% in regular trading, trading at $405.71/share, with turnover of $206 million. The stock rebounded as investors digested strong Q2 results and broader sector strength in healthcare facilities.

The company reported Q2 revenue of $20.23 billion, exceeding analyst estimates of $19.76 billion, while adjusted EPS came in at $7.59, surpassing consensus of $7.02 by over 8%. Same-facility admissions grew 2.5% year-over-year and emergency room visits rose 3.6%, underscoring resilient demand. Net income attributable to the company reached $1.699 billion, up 2.8% year-over-year. Management noted that expectations of reduced healthcare utilization among patients losing insurance coverage did not materialize, and long-term patient volume growth is projected at 2%-3% supported by demographic trends.

Despite analysts lowering price targets following guidance adjustments — Mizuho cut its target to $475 from $525 while maintaining Outperform, and Morgan Stanley reduced to $380 — the sector traded broadly higher, with Tenet Healthcare up 4.73%, Ensign up 3.03%, and Universal Health up 2.91%, providing additional tailwinds.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)